 HOUSTON, Jan. 04, 2021 GLOBE NEWSWIRE -- Aravive, Inc. Nasdaq: ARAV, a clinical-stage oncology company developing transformative therapeutics, today announced the Company will present at the H.C. Wainwright Virtual BioConnect Conference taking place January 11-14, 2021. Aravives presentation will be available for viewing on January 11, 2021. 